Targeted bisulfite sequencing for biomarker discovery
- PMID: 32755621
- PMCID: PMC7855209
- DOI: 10.1016/j.ymeth.2020.07.006
Targeted bisulfite sequencing for biomarker discovery
Abstract
Cytosine methylation is one of the best studied epigenetic modifications. In mammals, DNA methylation patterns vary among cells and is mainly found in the CpG context. DNA methylation is involved in important processes during development and differentiation and its dysregulation can lead to or is associated with diseases, such as cancer, loss-of-imprinting syndromes and neurological disorders. It has been also shown that DNA methylation at the cellular, tissue and organism level varies with age. To overcome the costs of Whole-Genome Bisulfite Sequencing, the gold standard method to detect 5-methylcytosines at a single base resolution, DNA methylation arrays have been developed and extensively used. This method allows one to assess the status of a fraction of the CpG sites present in the genome of an organism. In order to combine the relatively low cost of Methylation Arrays and digital signals of bisulfite sequencing, we developed a Targeted Bisulfite Sequencing method that can be applied to biomarker discovery for virtually any phenotype. Here we describe a comprehensive step-by-step protocol to build a DNA methylation-based epigenetic clock.
Keywords: Biomarker discovery; DNA methylation; Epigenetic clock; Next-generation sequencing; Target bisulfite-seq.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interest:
‘Declarations of interest: none’.
Figures
References
-
- Zhong X, Comparative epigenomics: a powerful tool to understand the evolution of DNA methylation, New Phytol. 210 (2016) 76–80. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
